Aims & Scope
Clinical Cancer Drugs publishes original research, expert reviews, and thematic issues covering all core areas of translational and clinical cancer drug research.
The journal publishes pre-clinical and clinical studies on the development of new anti-cancer agents. Clinical studies of new reported anti-cancer drugs include Phase 1–IV clinical trial studies, their designs, research methodologies, and analyses. The journal is essential reading to clinical oncologists, toxicologists, medicinal chemists, and pharmacologist.
Clinical Cancer Drugs is an international, peer-reviewed journal on all aspects of cancer drugs published continuously (print & online) by Bentham Science Publishers.
The journal publishes pre-clinical and clinical studies on the development of new anti-cancer agents. Clinical studies of new reported anti-cancer drugs include Phase 1–IV clinical trial studies, their designs, research methodologies, and analyses. The journal is essential reading to clinical oncologists, toxicologists, medicinal chemists, and pharmacologist.
Clinical Cancer Drugs is an international, peer-reviewed journal on all aspects of cancer drugs published continuously (print & online) by Bentham Science Publishers.
Abstracted & Indexed in:
British Library
Chemical Abstracts Service/SciFinder
CNKI Scholar
EBSCO
EMBASE
Google Scholar
J-Gate
JournalTOCs
OpenAire
PubsHub
QOAM
Scilit
Suweco CZ
Ulrich's Periodicals Directory
Journal Database:
Impact
CiteScore:1.3
View Details
Track Manuscript
- Call For Manuscript
- Submit Abstracts
- Submit Manuscripts
- Animated Abstract Submission
- Call For Thematic Issues
- Thematic Issue Proposal
- Submit Abstract To a Special Issue
